Switching from dulaglutide to tirzepatide boosts patient-reported well-being for people with type 2 diabetes: Analysis

An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in blood sugar and weight but also reported feeling emotionally better.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup